Carroll v. Guardant Health, Inc.

CourtDistrict Court, E.D. Pennsylvania
DecidedJanuary 5, 2021
Docket2:20-cv-03183
StatusUnknown

This text of Carroll v. Guardant Health, Inc. (Carroll v. Guardant Health, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carroll v. Guardant Health, Inc., (E.D. Pa. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

BILL CARROLL : CIVIL ACTION : v. : NO. 20-3183 : GUARDANT HEALTH, INC. :

MEMORANDUM KEARNEY, J. January 5, 2021 Employment discrimination arises in many forms. We today address discrimination claims and evidence adduced by a fifty-seven-year-old sales executive fired by his employer after weeks on the job. The employer now seeking judgment as a matter of law dismissing a terminated employee’s discrimination claims must demonstrate no genuine issue of material fact. We are often called upon to decide whether the employer’s stated reason for terminating the employee is pretext, or a cover-up, for discrimination against the employee based on his age or gender. We are not a super-personnel oversight department second-guessing an employer’s decision. But we must refer credibility decisions on genuine issues of material fact to trial if we find demonstrated inconsistencies in the employer’s practices which could suggest disparate treatment of the former sales executive. We do so today as to the sales executive’s claim for discrimination based on his age. Our issue arises from a national medical testing employer with a uniform human resources policy firing an at-will fifty-seven-year-old sales executive within weeks of recruiting him. His performance over his first weeks played no role in his firing. The employer fired him only because co-workers quoted him as asking, “what the f*** is Lesli’s problem?” and referring to women co-workers as “gals” or “f***ing chicks.” The sales executive claims he never said these words. He swears the male and female co-workers lied because they did not like him as the new guy recruited and mentored by the employer’s influential chief medical director. The parties do not tell us when he allegedly made these statements or when they reported these statements to their supervisors. The sales executive’s male supervisor and others investigated the alleged statements shortly after his colleagues exchanged text messages critical of the sales executive.

The supervisor shortly thereafter decided to fire him. The parties dispute whether the supervisor made his decision without affording him an independent investigation, an opportunity to specifically address the challenged remarks, or imposing less severe corrective action seemingly consistent with discipline under the employer’s policy and past investigations of similarly situated men for gender-based physical and verbal harassment directed at women. Following discovery, the adduced evidence confirms the employer did not similarly fire at least three younger males for their disputed physical and verbal harassment of female employees. It instead investigated the contradicted charges, prepared internal memoranda, and issued warnings or counseling consistent with its human resources policy. While true the investigated younger males worked for different departments with different supervisors, the

employer required all employees be similarly subject to the same standards and training to ensure a full, fair and proper investigation of gender-based harassment claims against co-workers. The sales executive adduces genuine issues of material fact as to whether his former employer discriminated against him on the basis of his age on a disparate treatment theory. The sales executive otherwise does not offer genuine issues of material fact precluding summary judgment as a matter of law dismissing his claims for: retaliation on the basis of his age; discrimination or retaliation on the basis of his sex; breach of contract; fraudulent inducement; defamation; and tortious interference with contractual relations. I. Undisputed Facts1 Bill Carroll is a fifty-seven-year-old man experienced in biotechnology and pharmaceutical sales.2 Mr. Carroll worked as a Senior Regional Sales Director, Northeast- Midwest for Veracyte, Inc. in early 2019.3 Mr. Carroll earned between $350,000 to $400,000 in

Veracyte stock options by early 2019. In spring 2019, Richard B. Lanman, Jr., M.D., Chief Medical Officer of Guardant Health, Inc., contacted Mr. Carroll regarding a position at Guardant.4 Guardant, a precision oncology company, developed a blood test to enable timely therapy selection for cancer patients.5 Dr. Lanman knew Mr. Carroll from their twenty-year friendship, including working together at Veracyte, and Mr. Carroll considered Dr. Lanman a mentor.6 On Dr. Lanman’s recommendation, Mr. Carroll flew to Texas and interviewed for the Regional Sales Director position at Guardant.7 Mr. Carroll interviewed with Steven Collora, Vice President of United States Oncology Sales.8 Mr. Collora told Mr. Carroll he “[saw] the company going a long way”; “he’s building a team that’s going to last”; and “we’re going to be here for a while.”9 He also “sold [Mr. Carroll] on . . . the future of the company,” and told Mr.

Carroll “the company would be better with [him], and that’s why he wanted to get [him] in.”10 Mr. Carroll made clear to Guardant he would not leave Veracyte, including $350,000 to $400,000 in existing stock options, to take a position with Guardant unless “they” assured him of a long-term opportunity, and he told Danielle Usilton, National Sales Director, he wanted to be “100 percent certain” he had a position at Guardant before resigning from Veracyte.11 Mr. Collora and Ms. Usilton led him to believe Guardant wanted him to be part of the company “long-term” and help grow Guardant over the next decade.12 Mr. Carroll claims Guardant, through Mr. Collora’s and Ms. Usilton’s comments during the interview process, fraudulently induced him to leave his position at Veracyte to accept the Regional Sales Direction position at Guardant. Mr. Carroll signs Guardant’s Employee Handbook ten days before resigning from Veracyte. In late May or early June 2019, Mr. Carroll reviewed Guardant’s Employee Handbook,

which included an employee acknowledgment section confirming, among other things: • he received the Employee Handbook and is responsible for reading it and complying with its policies;

• the Employee Handbook provides “guidelines only and are not intended to create any contractual rights or obligations, express or implied . . .”;

• his “employment with [Guardant] is at-will and not guaranteed for a specified length of time and can be terminated at any time, for any reason or for no reason, with or without cause or notice, by me or the company.”

• “no statements or representations regarding my employment can alter this policy.”

• “this Acknowledgment contains a full and complete statement of the agreements and understandings that it recites, that no one has made any promises or commitments to me contrary to the foregoing, and that this Acknowledgment supersedes all previous agreements, whether written or oral, express or implied, relating to the subjects covered in this Acknowledgment.”13

Mr. Carroll signed the employee acknowledgment on June 3, 2019.14 As Mr. Carroll’s counsel admitted during oral argument, Mr. Carroll signed the Acknowledgment confirming a potential position as an at-will executive approximately ten days before he resigned from Veracyte. Guardant’s Employee Handbook signed by Mr. Carroll before he resigned from Veracyte and weeks before accepting employment with Guardant contains a section entitled “Reporting and Investigating Harassing Conduct” providing, in part: • incidents of harassment should be reported to Human Resources, which is responsible for investigating harassment complaints;

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Price Waterhouse v. Hopkins
490 U.S. 228 (Supreme Court, 1989)
St. Mary's Honor Center v. Hicks
509 U.S. 502 (Supreme Court, 1993)
Harris v. Forklift Systems, Inc.
510 U.S. 17 (Supreme Court, 1993)
O'CONNOR v. Consolidated Coin Caterers Corp.
517 U.S. 308 (Supreme Court, 1996)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Gross v. FBL Financial Services, Inc.
557 U.S. 167 (Supreme Court, 2009)
English v. Colorado Department of Corrections
248 F.3d 1002 (Tenth Circuit, 2001)
Stagi v. National Railroad Passenger Corp.
391 F. App'x 133 (Third Circuit, 2010)
Anderson v. Wachovia Mortgage Corp.
621 F.3d 261 (Third Circuit, 2010)
Staub v. Proctor Hospital
131 S. Ct. 1186 (Supreme Court, 2011)
Lamont v. New Jersey
637 F.3d 177 (Third Circuit, 2011)
Ofelia Randle v. City of Aurora
69 F.3d 441 (Tenth Circuit, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
Carroll v. Guardant Health, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/carroll-v-guardant-health-inc-paed-2021.